Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Nunes

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Biological Research|February 16, 2005
To be or not to be ... nicotinic acid adenine dinucleotide phosphate (NAADP): a new intracellular second messenger?Eduardo Nunes Chini
Current Pharmaceutical Design|January 20, 2009
CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditionsEduardo Nunes Chini
Cell Metabolism|June 4, 2020
Of Mice and Men: NAD<sup>+</sup> Boosting with Niacin Provides Hope for Mitochondrial Myopathy PatientsEduardo Nunes Chini
Iranian Endodontic Journal|January 20, 2015
Apexification in non-vital teeth with immature roots: report of two casesRogério Vieira Silva, Frank Ferreira Silveira, Eduardo Nunes
Mayo Clinic Proceedings|June 11, 2005
Complications after unintentional intra-arterial injection of drugs: risks, outcomes, and management strategiesSurjya Sen, Eduardo Nunes Chini, Michael J Brown
Journal of Oral Science|April 13, 2007
Apical surgery with calcium hydroxide capping of the exposed dentine: a case reportJanir A Soares, Frank F Silveira, Eduardo Nunes
Journal of Chiropractic Medicine|February 27, 2023
Radiographic Measures for the Assessment of Frontal and Sagittal Knee Alignments and the Associated Normality Values: A Meta-AnalysisBruna Nichele da Rosa, Eduardo Nunes Camargo, Cláudia Tarragô Candotti
Current Opinion in Rheumatology|September 17, 2020
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritisThais Ribeiro Peclat, Bo Shi, John Varga, et al.
Physiological Reviews|September 8, 2021
Implications of the NADase CD38 in COVID pathophysiologyJulianna D Zeidler, Sonu Kashyap, Kelly A Hogan, et al.
Frontiers in Immunology|February 19, 2026
Regulating the regulators via targeting CD38 in the tumor microenvironmentNavnita Dutta, Nabanita Halder, Eduardo Nunes Chini, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Biological Research|February 16, 2005
To be or not to be ... nicotinic acid adenine dinucleotide phosphate (NAADP): a new intracellular second messenger?Eduardo Nunes Chini
Current Pharmaceutical Design|January 20, 2009
CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditionsEduardo Nunes Chini
Cell Metabolism|June 4, 2020
Of Mice and Men: NAD<sup>+</sup> Boosting with Niacin Provides Hope for Mitochondrial Myopathy PatientsEduardo Nunes Chini
Iranian Endodontic Journal|January 20, 2015
Apexification in non-vital teeth with immature roots: report of two casesRogério Vieira Silva, Frank Ferreira Silveira, Eduardo Nunes
Mayo Clinic Proceedings|June 11, 2005
Complications after unintentional intra-arterial injection of drugs: risks, outcomes, and management strategiesSurjya Sen, Eduardo Nunes Chini, Michael J Brown
Journal of Oral Science|April 13, 2007
Apical surgery with calcium hydroxide capping of the exposed dentine: a case reportJanir A Soares, Frank F Silveira, Eduardo Nunes
Journal of Chiropractic Medicine|February 27, 2023
Radiographic Measures for the Assessment of Frontal and Sagittal Knee Alignments and the Associated Normality Values: A Meta-AnalysisBruna Nichele da Rosa, Eduardo Nunes Camargo, Cláudia Tarragô Candotti
Current Opinion in Rheumatology|September 17, 2020
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritisThais Ribeiro Peclat, Bo Shi, John Varga, et al.
Physiological Reviews|September 8, 2021
Implications of the NADase CD38 in COVID pathophysiologyJulianna D Zeidler, Sonu Kashyap, Kelly A Hogan, et al.
Frontiers in Immunology|February 19, 2026
Regulating the regulators via targeting CD38 in the tumor microenvironmentNavnita Dutta, Nabanita Halder, Eduardo Nunes Chini, et al.
Pageof 13